Evidence map›Paper›PMID 26663941›Full record

ArticleNagoya journal of medical science2015

First year survival of patients on maintenance dialysis treatment in Poland.

Dorota Brodowska-Kania, Aleksandra Rymarz, Krzysztof Gibin Ski, Julia Kiełczewska, Jerzy Smoszna, Marek Saracyn, Katarzyna Szamotulska, Stanisław Niemczyk

Abstract read
In one paragraph

Article in Nagoya journal of medical science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Dorota Brodowska-KaniaDepartment of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, Warsaw, Poland.
Aleksandra RymarzDepartment of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, Warsaw, Poland.
Krzysztof Gibin SkiDepartment of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, Warsaw, Poland.
Julia KiełczewskaDepartment of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, Warsaw, Poland.
Jerzy SmosznaDepartment of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, Warsaw, Poland.
Marek SaracynDepartment of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, Warsaw, Poland.
Katarzyna SzamotulskaDepartment of Epidemiology, Institute of Mother and Child, Warsaw, Poland.
Stanisław NiemczykDepartment of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, Warsaw, Poland.
Wojskowy Instytut Medycyny Lotniczej · PLPolish Mother’s Memorial Hospital Research Institute · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retrospective analysis of demographic and clinical data of all patients starting dialysis over two years in our Department (n = 105) has been conducted. Factors such as type of dialysis treatment, reason of end-stage renal disease, Body Mass Index (BMI), laboratory tests results, number and cause of death during first year of dialysis were taken under consideration. Five patients have been excluded from the analysis of mortality (four received renal transplantation, one changed dialysis center). Twenty tree deaths have been noted during first year of dialysis treatment. Nine of them occurred during the first three months of therapy. The leading cause of death was cardio-vascular events (n = 14, 60.9%), the second was malignancy (8, 34,8%), one patient died due to catheter associated infection. Malignancy as a cause of end-stage renal disease, lack of outpatient nephrology care, acute mode of beginning renal replacement therapy and lack of erythropoiesis stimulating agents therapy were associated with higher risk of all-cause mortality during first year of dialysis. Being under the outpatient nephrology care, etiology of ESRD other than malignancy and erythropoiesis stimulating agents therapy were independently associated with better survival during this period of time. Other independent variables did not reach statistical significance. To conclude, in order to improve one year survival of dialysis patients, outpatient nephrology care with adequate amount of visits and associated dialysis therapy should be employed.

Indexed as

dialysisend-stage renal diseasemortalityrisk factors

Identifiers

PMID26663941
PMCPMC4664594
OpenAlexW2336832740

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.